journal article·2024-11-22

Macrophage Membrane-Camouflaged Prussian Blue-Based Nanoparticles for Targeted Photothermal-Dynamic Therapy against ESKAPE Pathogens and Improved Skin Infection Outcome

Guangyun Hu, Xiaoqing Zhou, Baohua Zhao, Yuan Peng, Qiyun Shi, Zhiqiang Yuan, Qin Shu, Wei Qian, Yizhi Peng

ACS Applied Nano Materials· Volume 7· Issue 22
Publisher page

Abstract

Infections caused by Enterococcus fascism, Staphylococcus aureus, Klebsiella pneumonia, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species (ESKAPE) bacteria and their biofilms considerably threaten human health. Developing antibacterial agents against ESKAPE bacteria and controlling related inflammation are urgently needed. Herein, we developed a nanosystem by coating M1 macrophage membranes onto the surface of Prussian Blue@polydopamine@IR820 nanoparticles (PDIM NPs) for determining the antimicrobial activity against skin and soft tissue infection. Upon administration, PDIM NPs actively aggregated in the infected regions of subcutaneous abscesses owing to their homologous targeting properties. Under irradiation with a near-infrared (NIR) 808 nm laser, PDIM NPs exhibited outstanding antibacterial effects via synergistic photothermal and photodynamic therapy. Thereafter, the naked Prussian Blue-based nanoparticles effectively scavenged excessive reactive oxygen species and alleviated inflammation. The mouse model demonstrated the regulation of angiogenesis, collagen deposition, and attenuated hyperinflammation. Furthermore, PDIM NPs exhibited excellent biosafety in vitro and in vivo . Therefore, PDIM NPs showed remarkable infectious site-targeting properties and antimicrobial performances and facilitated the healing of cutaneous abscesses, providing strategies for treating ESKAPE bacteria and biofilm-associated diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Medical and Biological Ozone Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Burn Research, State Key Laboratory of Trauma and Chemical Poisoning, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China

School of Nursing, Laboratory of Trauma Care, School of Nursing Army Medical University, Chongqing 400038, China

Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China

Department of Thyroid and Breast Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China

Funding

Natural Science Foundation of Chongqing · Natural Science Foundation of China

References (63)

Show source-provided references
1. 10.1128/CMR.00181-1910.1128/CMR.00181-19 ↗
2. 10.1016/S1473-3099(17)30753-310.1016/S1473-3099(17)30753-3 ↗
3. 10.1002/anie.20120997910.1002/anie.201209979 ↗
4. 10.1016/j.biomaterials.2021.12124910.1016/j.biomaterials.2021.121249 ↗
5. 10.1016/j.jconrel.2020.08.05510.1016/j.jconrel.2020.08.055 ↗
6. 10.3390/pharmaceutics1508210610.3390/pharmaceutics15082106 ↗
7. 10.1021/ja066273x10.1021/ja066273x ↗
8. 10.1002/adhm.20180034710.1002/adhm.201800347 ↗
9. 10.1038/s41467-019-12429-610.1038/s41467-019-12429-6 ↗
10. 10.1016/j.biomaterials.2022.12198010.1016/j.biomaterials.2022.121980 ↗
11. 10.1016/j.biomaterials.2020.11982710.1016/j.biomaterials.2020.119827 ↗
12. 10.1002/tcr.20160012110.1002/tcr.201600121 ↗
13. 10.1016/j.biomaterials.2019.04.02410.1016/j.biomaterials.2019.04.024 ↗
14. 10.1016/j.bioactmat.2020.04.00310.1016/j.bioactmat.2020.04.003 ↗
15. 10.1021/acsami.2c0057410.1021/acsami.2c00574 ↗
16. 10.1039/D2BM00835A10.1039/D2BM00835A ↗
17. 10.1039/C8NR10430A10.1039/C8NR10430A ↗
18. 10.3389/fbioe.2022.98416610.3389/fbioe.2022.984166 ↗
19. 10.1039/C9BM00599D10.1039/C9BM00599D ↗
20. 10.1002/adma.20170675910.1002/adma.201706759 ↗
21. 10.1002/adma.20180402310.1002/adma.201804023 ↗
22. 10.1007/s00018-015-1995-y10.1007/s00018-015-1995-y ↗
23. 10.1039/D1BM01664D10.1039/D1BM01664D ↗
24. 10.1016/j.biomaterials.2020.12015910.1016/j.biomaterials.2020.120159 ↗
25. 10.1002/adfm.20200494210.1002/adfm.202004942 ↗
26. 10.1016/j.biomaterials.2020.11993610.1016/j.biomaterials.2020.119936 ↗
27. 10.1088/1361-6528/ab5d8410.1088/1361-6528/ab5d84 ↗
28. 10.1021/acs.nanolett.7b0526310.1021/acs.nanolett.7b05263 ↗
29. 10.1080/10717544.2018.150283910.1080/10717544.2018.1502839 ↗
30. 10.1016/j.biomaterials.2019.04.02610.1016/j.biomaterials.2019.04.026 ↗
31. 10.1073/pnas.141242011110.1073/pnas.1412420111 ↗
32. 10.1002/adma.20120468310.1002/adma.201204683 ↗
33. 10.1021/acsnano.9b0987110.1021/acsnano.9b09871 ↗
34. 10.1021/acsami.6b1126210.1021/acsami.6b11262 ↗
35. 10.1039/C8BM00812D10.1039/C8BM00812D ↗
36. 10.1016/j.jhazmat.2022.12861610.1016/j.jhazmat.2022.128616 ↗
37. Grossman A. B. · 2021 · 2341 · 6910.1007/978-1-0716-1550-8_9 ↗
38. 10.1016/j.snb.2023.13376210.1016/j.snb.2023.133762 ↗
39. 10.1186/s12951-023-02144-210.1186/s12951-023-02144-2 ↗
40. 10.2217/nnm-2019-015410.2217/nnm-2019-0154 ↗
41. 10.3109/09553002.2013.78244810.3109/09553002.2013.782448 ↗
42. 10.1016/j.actbio.2020.07.04310.1016/j.actbio.2020.07.043 ↗
43. 10.1016/j.drudis.2020.05.01410.1016/j.drudis.2020.05.014 ↗
44. 10.3390/pharmaceutics1509224310.3390/pharmaceutics15092243 ↗
45. 10.1016/j.tiv.2016.08.00710.1016/j.tiv.2016.08.007 ↗
46. 10.1002/jbm.a.3668510.1002/jbm.a.36685 ↗
47. 10.1002/adhm.20230239110.1002/adhm.202302391 ↗
48. 10.1186/s12951-022-01746-610.1186/s12951-022-01746-6 ↗
49. 10.1039/C9BM01207A10.1039/C9BM01207A ↗
50. 10.1021/acsnano.3c0585310.1021/acsnano.3c05853 ↗
51. 10.1016/j.bioactmat.2022.06.01310.1016/j.bioactmat.2022.06.013 ↗
52. 10.1016/j.biomaterials.2023.12203610.1016/j.biomaterials.2023.122036 ↗
53. 10.1186/s12951-021-01106-w10.1186/s12951-021-01106-w ↗
54. 10.1126/sciadv.abn170110.1126/sciadv.abn1701 ↗
55. 10.1101/cshperspect.a04122510.1101/cshperspect.a041225 ↗
56. 10.1186/s12951-024-02390-y10.1186/s12951-024-02390-y ↗
57. 10.1016/j.celrep.2023.11264710.1016/j.celrep.2023.112647 ↗
58. 10.1016/j.immuni.2014.10.00810.1016/j.immuni.2014.10.008 ↗
59. 10.1007/s40820-015-0040-x10.1007/s40820-015-0040-x ↗
60. 10.1002/jat.161110.1002/jat.1611 ↗
61. 10.2478/aiht-2020-71-336410.2478/aiht-2020-71-3364 ↗
62. 10.1039/D0TB01248C10.1039/D0TB01248C ↗
63. 10.1186/s12951-021-00840-510.1186/s12951-021-00840-5 ↗